HOME >> BIOLOGY >> NEWS
Newly Discovered Gene Halts Cell Division and May Have Cancer Link

ntial role in the cell cycle, Dr. Benezra says. After a cell's DNA is copied, each pair of the duplicated chromosomes is bound together at structures, called centromeres, that fit around each chromosome like a napkin ring. In order for a cell to divide, thread-like fibers must attach to each centromere and pull the chromosomes apart. That's where the MAD2 gene comes in.

The research suggests that MAD2 produces a protein that sits at the centromere of each chromosome and waits for the thread-like fibers to attach. If the fibers attach properly, cell division proceeds and each new cell gets a complete copy of the genetic blueprint of the original cell. But if the fibers fail to anchor to one of the centromeres, the corresponding chromosome pair can't separate normally and MAD2 puts the brakes on cell division.

Dr. Benezra speculates that MAD2 is only one of several genes involved in triggering this cell division checkpoint. In yeast, for example, six genes are known to exert their control over the checkpoint. Dr. Benezra, whose team discovered the MAD2 gene by accident, also is investigating a second human gene suspected of being involved in the checkpoint.

The new research may help to improve future treatment options for cancer patients. In the study, the researchers identified a human breast tumor cell line that is sensitive to the cancer drugs taxol and nocodazole. The drugs, called spindle inhibitors, block the formation of the thread-like fibers that pull chromosomes apart during cell division.

After the researchers treated the breast tumor cell line with nocodazole, the cells continued to undergo cell division, which suggests the cells may be defective in the checkpoint. When the investigators looked further, they confirmed their suspicion -- the cell line had low levels of MAD2 expression compared to control cells that were resistant to both drugs.

The drugs may be especially effective in the treatment of tumors with a defective checkpoint,
'"/>

Contact: Chris Westerman
westermac@mskcc.org
212-639-3576
Memorial Sloan-Kettering Cancer Center
11-Oct-1996


Page: 1 2 3

Related biology news :

1. Newly identified master gene key in babys first breath
2. Newly discovered protein may be key to muscular dystrophy
3. Newly designed nanoparticle quantum dots simultaneously target and image prostate tumors in mice
4. Newly grown kidneys can sustain life in rats
5. Newly discovered gene controls levels of bad cholesterol in mice
6. Newly identified gene linked to brain development
7. Newly cloned gene key to global adaptation of wheat
8. Newly identified genes may help predict outcome in childhood leukemia
9. Newly identified gene may halt fuzzy, moldy fruit
10. Newly found gene resistant to economically crippling wheat disease
11. Newly invented Endometrial Function Test (EFT®) solves the puzzle of unexplained infertility

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/16/2016)... NEW YORK , May 16, 2016   ... authentication solutions, today announced the opening of an IoT ... to strengthen and expand the development of embedded ... provides an unprecedented level of convenience and security with ... to authenticate one,s identity aside from DNA. EyeLock,s platform ...
(Date:5/9/2016)... 2016 Elevay is currently known ... freedom for high net worth professionals seeking travel for ... connected world, there is still no substitute for a ... sealing your deal with a firm handshake. This is ... advantage of citizenship via investment programs like those offered ...
(Date:4/28/2016)... FRANCISCO and BANGALORE, India , ... of EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... provider, today announced a global partnership that will ... way to use mobile banking and payment services. ... is a key innovation area for financial services, but it ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... June 27, 2016 , ... ... innovative medical technologies, services and solutions to the healthcare market. The company's primary ... various distribution, manufacturing, sales and marketing strategies that are necessary to help companies ...
(Date:6/24/2016)... 2016 Epic Sciences unveiled a liquid ... to PARP inhibitors by targeting homologous recombination deficiency ... new test has already been incorporated into numerous ... types. Over 230 clinical trials are ... including PARP, ATM, ATR, DNA-PK and WEE-1. Drugs ...
(Date:6/23/2016)...   Boston Biomedical , an industry leader ... target cancer stemness pathways, announced that its lead ... Designation from the U.S. Food and Drug Administration ... gastroesophageal junction (GEJ) cancer. Napabucasin is an orally ... stemness pathways by targeting STAT3, and is currently ...
(Date:6/23/2016)... SANTA MONICA, Calif. , June 23, 2016  The Prostate Cancer ... to pioneer increasingly precise treatments and faster cures for prostate cancer. Members of ... 77 institutions across 15 countries. Read More About the ... ... ...
Breaking Biology Technology:
Cached News: